Stay updated on Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page.

Latest updates to the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision metadata updated from v3.6.2 to v3.6.3, indicating a minor maintenance update to the Study Details page. This change appears to be a version bump rather than a substantive modification of the page content.SummaryDifference0.0%

- Check23 days agoChange DetectedThe page's revision tag has been updated from v3.6.0 to v3.6.2, with the older tag removed. This update seems to reflect a backend or template change rather than a user-facing content modification.SummaryDifference0.0%

- Check37 days agoChange DetectedNew navigation items and help sections were added to the study page, including How to Read a Study Record, Common Questions, How to Join a Study, and Intervention/Treatment, along with a revision note to v3.6.0. The recruitment status now shows no longer looking for participants.SummaryDifference0.5%

- Check44 days agoChange DetectedPage revision label updated from v3.5.4 to v3.5.5, indicating a minor revision of the document. This change signals a version bump and does not modify the stated study details or eligibility information.SummaryDifference0.0%

- Check59 days agoChange DetectedSponsor for the MOR106 study is updated, switching the listed sponsor from Galapagos NV to Lakefront Biotherapeutics NV.SummaryDifference0.2%

- Check66 days agoChange DetectedThe page shows Revision: v3.5.4 instead of v3.5.3, representing a minor version update. This update does not modify the visible content or functionality of the page.SummaryDifference0.0%

Stay in the know with updates to Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page.